Download Files:
FAAH/MAGL-IN-5
SKU
HY-77491-1 mg
Category Reference compound
Tags FAAH;MAGL, Metabolic Enzyme/Protease;Neuronal Signaling, Neurological Disease
$100 – $1,120
Products Details
Product Description
– AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects[1].
Web ID
– HY-77491
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C17H17N5O
References
– [1]Vinogran Naidoo, et al.Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase – dual targets of the endocannabinoid system to protect against seizure pathology.Neurotherapeutics.2012 Oct;9(4):801-13.
CAS Number
– 1010096-65-7
Molecular Weight
– 307.35
Compound Purity
– 99.17
SMILES
– O=C(N1N=C(CC2=CC=C(C3=CC=CC=C3)C=C2)N=N1)N(C)C
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– FAAH;MAGL
Pathway
– Metabolic Enzyme/Protease;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.